Updated:
China Science & Merchants Capital Management
单祥双's government-registered PE platform bridges Chinese policy capital and hard-tech venture, with UBTECH and 晶科电子 IPOs marking recent exits.
China Science & Merchants Capital Management
Founded in Shenzhen and now headquartered in Beijing, China Science & Merchants Capital Management operates as a government-approved private equity manager focused on technology innovation. Chairman and President 单祥双, a former executive at China Merchants Group and China Merchants Securities, established the firm with a mandate formalized through state registration — distinguishing it from the unregistered general partners that once proliferated in China's venture market. The firm deploys capital across early-stage, growth, and pre-IPO rounds, with a stated strategy of direct investments followed by public listings on venues like the Hong Kong Stock Exchange. Portfolio exits include the December 2023 IPO of humanoid robotics maker 优必选 (UBTECH, 9880 HK) and the November 2024 listing of LED component manufacturer 晶科电子 on the HKEX main board. Other known positions include 诺思, a specialty semiconductor firm recognized under China's national "Little Giant" program, and an earlier cross-border commitment to US-based AngelList — a deal the firm frames as pioneering Chinese institutional capital into Silicon Valley fundraising infrastructure. The group maintains a Beijing headquarters but the founder's biography and the firm's incorporation narrative both trace to Shenzhen. In June 2024, the firm held its annual shareholder meeting and passed all seven agenda items, signaling continued alignment between its state-rooted charter and private-capital execution. 单祥双 publicly articulates a "three-base project" — fund formation, operational platforms, and industrial ecosystem integration — as the operational template, suggesting an architecture that combines limited-partner fund management with direct operating-company involvement. Structurally, the firm sits at the intersection of private venture capital and China's industrial-policy apparatus. Its registration as a government-sanctioned investment institution, combined with a portfolio concentrated in firms tagged as national strategic champions, separates it from purely return-driven VC syndicates. The succession and governance model remains personified in 单祥双, now nearly three decades into his career, with no publicly signaled leadership transition.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Principals
单祥双 (Shan Xiangshuang)
董事长兼总裁 (Chairman & President)
Sector focus
Frequently asked questions
Who runs China Science & Merchants Capital?
单祥双 serves as Chairman and President, holding sole operational authority based on the firm's disclosures. A graduate of Xiamen University, Harbin Institute of Technology, and Tsinghua's PBC School of Finance, he previously held roles at China's Ministry of Education, Ministry of Transport, and China Merchants Securities. His social appointments include vice chairman of the Chinese Society of Aeronautics and Astronautics.
How does the firm source its investment pipeline?
The firm's sourcing appears dual-track: a domestic policy-aligned channel that surfaces national strategic enterprises like specialty semiconductor firms, and a cross-border origination capability demonstrated by the AngelList commitment. Public materials emphasize the founder's own network built across state commissions and the Shenzhen–Beijing corridor.
Is China Science & Merchants a fund-of-funds or a direct investor?
It operates as a direct investor and fund manager across the full company lifecycle, from seed-stage startups to pre-IPO companies. Its recent exits — UBTECH and 晶科电子 — were direct equity positions that reached public markets on the Hong Kong Stock Exchange.
What listing venues does the firm target for exits?
Recent disclosed exits have all materialized on the Hong Kong Stock Exchange, including the UBTECH IPO in December 2023 and the 晶科电子 listing in November 2024. The HKEX serves as the primary liquidity path for its hard-tech portfolio companies.
What is the firm's relationship to the Chinese government?
The firm describes itself as a 'government-approved' investment management institution, a registration that embeds regulatory and policy alignment into its charter. Its portfolio includes 'Little Giant' enterprises — a designation under China's Ministry of Industry and Information Technology for strategically important SMEs — reinforcing the link between investment selection and state industrial goals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: